Brief: Moberg Pharma Board Of Directors And Nomination Committee Have Proposed Appointment Of Anna Ljung As New CEO

Moberg Pharma AB (publ)

08/04/2019 15:11

April 8 (Reuters) - Moberg Pharma AB (publ)  MBPH.ST :
    * BOARD OF DIRECTORS AND NOMINATION COMMITTEE HAVE  PROPOSED APPOINTMENT OF ANNA LJUNG AS
NEW CEO
OF MOBERG PHARMA
    * CURRENT CEO PETER WOLPERT WILL TRANSITION TO A ROLE AS EXECUTIVE CHAIRMAN OF BOARD OF
DIRECTORS
    * ORGANIZATIONAL CHANGES ARE CONTINGENT ON APPROVAL OF ANNUAL GENERAL MEETING (AGM) AND
BOARD OF
DIRECTORS ELECTED BY AGM.

Source text for Eikon:  ID:nWkr14LmQ4 
Further company coverage:  MBPH.ST 

 (Gdynia Newsroom)
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))